RBF Capital’s GeneDx Holdings WGS Stock Holding History

RBF Capital’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.4M	Hold	37,340	–	–	0.12%	158
2025 Q4	$4.86M	Hold	37,340	–	–	0.22%	106
2025 Q3	$4.02M	Hold	37,340	–	–	0.18%	120
2025 Q2	$3.45M	Hold	37,340	–	–	0.16%	129
2025 Q1	$3.31M	Hold	37,340	–	–	0.2%	118
2024 Q4	$2.87M	Hold	37,340	–	–	0.15%	147
2024 Q3	$1.58M	Hold	37,340	–	–	0.08%	233
2024 Q2	$976K	Sell	37,340 -12,660	-25%	-$240K	0.06%	278
2024 Q1	$457K	Hold	50,000	–	–	0.03%	412
2023 Q4	$138K	Sell	50,000 -20,000	-29%	-$46.5K	0.01%	516
2023 Q3	$255K	Hold	70,000	–	–	0.02%	446
2023 Q2	$417K	Buy	+70,000	New	+$554K	0.03%	383

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RBF Capital's WGS Position: Q1 2026 in Review

RBF Capital held its GeneDx Holdings (WGS) position steady in Q1 2026 at 37,340 shares worth $2.4M. The position accounts for 0.12% of the portfolio, ranked #158.

RBF Capital first reported a position in WGS in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.86M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

RBF Capital held 37,340 shares of GeneDx Holdings worth $2.4M as of Q1 2026.
RBF Capital left its GeneDx Holdings share count unchanged in Q1 2026.
GeneDx Holdings made up 0.12% of RBF Capital's portfolio in Q1 2026, its #158 holding.
RBF Capital first reported a position in GeneDx Holdings in Q2 2023 and has held it in 12 quarters since.
RBF Capital's GeneDx Holdings position peaked at $4.86M in Q4 2025.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on RBF Capital's 13F filing for Q1 2026, filed 15 May 2026.